LTRN
Lantern Pharma
$0.73
−$0.04 (−5.56%)Oct 29, 2026
Key metrics
The numbers that frame LTRN today
- Market cap
- $9.35M
- ROIC
- 27,389.9%
- Div yield
- 0%
- 52wk Low
- $0.59
- 52wk High
- $4.34
Growth
Revenue and earnings trend for LTRN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LTRN
Is Lantern Pharma a good buy?
No. Lantern Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Lantern Pharma is selling at a very high price.
What is the market capitalization of LTRN?
Lantern Pharma's market capitalization is $9.35M.
What is the 52-week high for LTRN stock?
The 52-week high for Lantern Pharma is $4.34. The current close of $0.73 is 83.2% below that high.
What is the 52-week low for LTRN stock?
The 52-week low for Lantern Pharma is $0.59. The current close of $0.73 is 23.7% above that low.
Does LTRN stock pay dividends?
Lantern Pharma does not currently show a dividend per share in the company data.